BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 9722802)

  • 21. Social and cultural barriers to Papanicolaou test screening in an urban population.
    Behbakht K; Lynch A; Teal S; Degeest K; Massad S
    Obstet Gynecol; 2004 Dec; 104(6):1355-61. PubMed ID: 15572502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of intent to seek unnecessary pap tests among elderly women.
    Zhang Y; Borders TF; Rohrer JE
    Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproductive health in lesbian and bisexual women in Sweden.
    Moegelin L; Nilsson B; Helström L
    Acta Obstet Gynecol Scand; 2010; 89(2):205-9. PubMed ID: 20121335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative.
    Hsia J; Kemper E; Kiefe C; Zapka J; Sofaer S; Pettinger M; Bowen D; Limacher M; Lillington L; Mason E
    Prev Med; 2000 Sep; 31(3):261-70. PubMed ID: 10964640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pap smear screening among urban Southwestern American Indian women.
    Risendal B; DeZapien J; Fowler B; Papenfuss M; Giuliano A
    Prev Med; 1999 Dec; 29(6 Pt 1):510-8. PubMed ID: 10600432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Papanicolaou test status among inner-city adolescent girls.
    Najem GR; Batuman F; Smith AM
    Am J Prev Med; 1996; 12(6):482-6. PubMed ID: 8955780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The roles of citizenship status, acculturation, and health insurance in breast and cervical cancer screening among immigrant women.
    Echeverria SE; Carrasquillo O
    Med Care; 2006 Aug; 44(8):788-92. PubMed ID: 16862042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Awareness of breast and cervical cancer risk factors and screening behaviours among nurses in rural region of Turkey.
    Yaren A; Ozkilinc G; Guler A; Oztop I
    Eur J Cancer Care (Engl); 2008 May; 17(3):278-84. PubMed ID: 18419631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative and mixed analyses to identify factors that affect cervical cancer screening uptake among lesbian and bisexual women and transgender men.
    Johnson MJ; Mueller M; Eliason MJ; Stuart G; Nemeth LS
    J Clin Nurs; 2016 Dec; 25(23-24):3628-3642. PubMed ID: 27240268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do cervical cancer screening patient information leaflets meet the HPV information needs of women?
    Hall B; Howard K; McCaffery K
    Patient Educ Couns; 2008 Jul; 72(1):78-87. PubMed ID: 18372144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. English proficiency and physicians' recommendation of Pap smears among Hispanics.
    De Alba I; Sweningson JM
    Cancer Detect Prev; 2006; 30(3):292-6. PubMed ID: 16844320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knowledge, attitudes, and practice related to cervical cancer screening among Kuwaiti women.
    Al Sairafi M; Mohamed FA
    Med Princ Pract; 2009; 18(1):35-42. PubMed ID: 19060489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence characteristics after abnormal screening results between mammogram and Papanicolaou test groups.
    Fang SY; Shu BC
    Cancer Nurs; 2009; 32(6):437-45. PubMed ID: 19816157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pap prevalence and cervical cancer prevention among Alaska Native women.
    Lanier AP; Kelly JJ; Holck P
    Health Care Women Int; 1999; 20(5):471-86. PubMed ID: 10776116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of gynecologic health care problems between lesbians and bisexual women. A survey of 2,345 women.
    Johnson SR; Smith EM; Guenther SM
    J Reprod Med; 1987 Nov; 32(11):805-11. PubMed ID: 3430489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why women still die from cervical cancer.
    Masood S
    J Fla Med Assoc; 1997; 84(6):379-83. PubMed ID: 9379163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical cancer screening among Taiwanese women: a transtheoretical approach.
    Tung WC; Lu M; Cook D
    Oncol Nurs Forum; 2010 Jul; 37(4):E288-94. PubMed ID: 20591792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical cancer screening (Pap testing) behaviours and acceptability of human papillomavirus self-testing among lesbian and bisexual women aged 21-26 years in the USA.
    Reiter PL; McRee AL
    J Fam Plann Reprod Health Care; 2015 Oct; 41(4):259-64. PubMed ID: 25385868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
    Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
    Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.